Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 1
2008 1
2012 1
2015 2
2017 1
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study.
Conforti F, Gronchi A, Penel N, Jones RL, Broto JM, Sala I, Bagnardi V, Napolitano A, Pala L, Pennacchioli E, Catania C, Queirolo P, Grigani G, Merlini A, Stacchiotti S, Comandone A, Vincenzi B, Quagliuolo V, Bertuzzi A, Boglione A, Palassini E, Baldi GG, Blay JY, Ryckewaert T, Toulmonde M, Italiano A, Le Cesne A, Ray-Coquard I, Cruz J, Hernández-León CN, Trufero JM, da Silva Moura D, Muñiz NH, De Pas T. Conforti F, et al. Among authors: trufero jm. Eur J Cancer. 2022 Aug;171:183-192. doi: 10.1016/j.ejca.2022.04.030. Epub 2022 Jun 18. Eur J Cancer. 2022. PMID: 35728378
Brain metastases from colorectal carcinoma.
Zorrilla M, Alonso V, Herrero A, Corral M, Puértolas T, Trufero JM, Artal A, Antón A. Zorrilla M, et al. Among authors: trufero jm. Tumori. 2001 Sep-Oct;87(5):332-4. doi: 10.1177/030089160108700511. Tumori. 2001. PMID: 11765184
Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC).
Pazo-Cid RA, Lanzuela M, Esquerdo G, Pérez-Gracia JL, Antón A, Amigo G, Trufero JM, García-Otín AL, Martín-Duque P. Pazo-Cid RA, et al. Among authors: trufero jm. Clin Transl Oncol. 2012 Aug;14(8):564-74. doi: 10.1007/s12094-012-0842-y. Epub 2012 Jul 18. Clin Transl Oncol. 2012. PMID: 22855137
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
Hidalgo-Ríos S, Carrillo-García J, Moura DS, Stacchiotti S, López-Pousa A, Redondo A, Italiano A, Gutiérrez A, Grignani G, Hindi N, López-Guerrero JA, Muro XGD, Trufero JM, Palmerini E, García AS, Bernabeu D, Le Cesne A, Casali PG, Blay JY, Cruz Jurado J, Martin-Broto J. Hidalgo-Ríos S, et al. Among authors: trufero jm. Cancers (Basel). 2022 Aug 29;14(17):4186. doi: 10.3390/cancers14174186. Cancers (Basel). 2022. PMID: 36077723 Free PMC article.
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain.
Carrillo-García J, Lacerenza S, Hindi N, García IC, Marquina G, Cano Cano JM, Trufero JM, Sevillano Tripero AR, Luis García T, Cuesta Rioboo MJ, Moura DS, Renshaw M, Mondaza-Hernández JL, Di Lernia D, Gutierrez A, Martin-Broto J. Carrillo-García J, et al. Among authors: trufero jm. Ther Adv Med Oncol. 2024 Jan 9;16:17588359231220611. doi: 10.1177/17588359231220611. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38205079 Free PMC article.
Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192].
Conforti F, Gronchi A, Penel N, Jones RL, Broto JM, Sala I, Bagnardi V, Napolitano A, Pala L, Pennacchioli E, Catania C, Queirolo P, Grigani G, Merlini A, Stacchiotti S, Comandone A, Vincenzi B, Quagliuolo V, Bertuzzi A, Boglione A, Palassini E, Baldi GG, Blay JY, Ryckewaert T, Toulmonde M, Italiano A, Le Cesne A, Ray-Coquard I, Cruz J, Hernández-León CN, Trufero JM, da Silva Moura D, Muñiz NH, De Pas T. Conforti F, et al. Among authors: trufero jm. Eur J Cancer. 2023 May;184:197-198. doi: 10.1016/j.ejca.2022.11.027. Epub 2023 Mar 10. Eur J Cancer. 2023. PMID: 36907702 No abstract available.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Machiels JP, Haddad RI, Fayette J, Licitra LF, Tahara M, Vermorken JB, Clement PM, Gauler T, Cupissol D, Grau JJ, Guigay J, Caponigro F, de Castro G Jr, de Souza Viana L, Keilholz U, Del Campo JM, Cong XJ, Ehrnrooth E, Cohen EE; LUX-H&N 1 investigators. Machiels JP, et al. Lancet Oncol. 2015 May;16(5):583-94. doi: 10.1016/S1470-2045(15)70124-5. Epub 2015 Apr 16. Lancet Oncol. 2015. PMID: 25892145 Clinical Trial.
12 results